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Interaction of ZPR1 with Translation Elongation 
 
Factor-1
 
a
 
 in Proliferating Cells
 
Laxman Gangwani, Monique Mikrut, Zoya Galcheva-Gargova, and Roger J. Davis
 
Howard Hughes Medical Institute and Program in Molecular Medicine, Department of Biochemistry and Molecular Biology, 
University of Massachusetts Medical School, Worcester, Massachusetts 01605
 
Abstract. 
 
The zinc finger protein ZPR1 is present in 
the cytoplasm of quiescent mammalian cells and trans-
locates to the nucleus upon treatment with mitogens, 
including epidermal growth factor (EGF). Homologues 
of ZPR1 were identified in yeast and mammals. These 
ZPR1 proteins bind to eukaryotic translation elonga-
tion factor-1
 
a
 
 (eEF-1
 
a
 
). Studies of mammalian cells 
demonstrated that EGF treatment induces the interac-
tion of ZPR1 with eEF-1
 
a
 
 and the redistribution of 
both proteins to the nucleus. In the yeast 
 
Saccharomy-
ces cerevisiae
 
, genetic analysis demonstrated that 
 
ZPR1
 
 
is an essential gene. Deletion analysis demonstrated 
that the NH
 
2
 
-terminal region of ZPR1 is required for 
normal growth and that the COOH-terminal region 
was essential for viability in 
 
S
 
.
 
 cerevisiae
 
. The yeast 
ZPR1 protein redistributes from the cytoplasm to the 
nucleus in response to nutrient stimulation. Disruption 
of the binding of ZPR1 to eEF-1
 
a
 
 by mutational analy-
sis resulted in an accumulation of cells in the G2/M 
phase of cell cycle and defective growth. Reconstitution 
of the ZPR1 interaction with eEF-1
 
a
 
 restored normal 
growth. We conclude that ZPR1 is essential for cell via-
bility and that its interaction with eEF-1
 
a
 
 contributes 
to normal cellular proliferation. 
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he 
 
zinc finger protein ZPR1 is located in the
cytoplasm of quiescent mammalian cells (Galcheva-
Gargova et al., 1996). Treatment with mitogens,
including epidermal growth factor (EGF), causes the re-
distribution of ZPR1 from the cytoplasm to the nucleus
(Galcheva-Gargova et al., 1996). The function of ZPR1 in
the nucleus has not been defined. However, the nuclear
redistribution of ZPR1 in proliferating cells suggests that
this protein may act as a signaling molecule that communi-
cates mitogenic signals from the cytoplasm to the nucleus.
The mechanism of cytoplasmic retention of ZPR1 in
quiescent cells is unclear. ZPR1 binds to a group of ty-
rosine kinase receptors, including the EGF and platelet-
derived growth factor receptors (Galcheva-Gargova et al.,
1996). The binding of ZPR1 to these receptors is blocked
after mitogen stimulation (Galcheva-Gargova et al., 1996).
It is therefore possible that ZPR1 may be sequestered in
the cytoplasm by receptors in quiescent cells and that the
mitogen-stimulated release of ZPR1 from these receptors
may trigger the accumulation of ZPR1 in the nucleus. Al-
though this is a plausible hypothesis, it appears that this
possible mechanism represents an oversimplification of
the processes that control the subcellular localization of
ZPR1. First, it is unclear whether the relative abundance
of receptors and ZPR1 is sufficient to account for the cyto-
plasmic sequestration of ZPR1 in quiescent cells. Second,
ZPR1 lacks an obvious nuclear localization sequence that
could direct nuclear accumulation when ZPR1 is released
from receptor complexes. Third, in the present study, we
find that the nuclear localization of ZPR1 is regulated in
cells that lack tyrosine kinase receptors. These consider-
ations suggest that the interaction of ZPR1 with other bio-
molecules may contribute to the regulation of the subcel-
lular distribution of ZPR1.
Although it is known that ZPR1 binds to cell surface re-
ceptor molecules in quiescent cells, it is not established
whether the effect of mitogens to inhibit the ZPR1/recep-
tor interaction represents the formation of a novel ZPR1
complex with a different protein. The purpose of the study
described in this report was to identify a protein that inter-
acts with ZPR1 after treatment of cells with mitogens. This
study was facilitated by the identification of ZPR1 homo-
logues in mammals and yeast.
We report that ZPR1 binds to eukaryotic translation
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elongation factor-1
 
a
 
 (eEF-1
 
a
 
).
 
1
 
 EGF stimulation of mam-
malian cells triggers the formation ZPR1/eEF-1
 
a
 
 com-
plexes and the translocation of both ZPR1 and eEF-1
 
a
 
from the cytoplasm to the nucleus. Similarly, in the yeast
 
S
 
.
 
 cerevisiae
 
, ZPR1 redistributes between the cytoplasm
and the nucleus in response to nutrient stimulation. Dis-
ruption of the 
 
ZPR1
 
 gene is lethal in 
 
S
 
.
 
 cerevisiae
 
. Dele-
tion analysis demonstrated that ZPR1 can be divided into
two functional domains. The NH
 
2
 
-terminal region of
ZPR1 is required for normal growth whereas the COOH-
terminal region is essential for viability. Disruption of the
binding between ZPR1 and eEF-1
 
a
 
 by mutational analysis
caused the accumulation of cells in the G2/M phase of the
cell cycle and defective growth. Reconstitution of the
ZPR1 interaction with eEF-1
 
a
 
 by inter-allelic complemen-
tation restored normal growth. These data establish a role
for the formation of nuclear ZPR1/eEF-1
 
a
 
 complexes in
the normal growth of proliferating cells.
Previous studies have demonstrated that eEF-1
 
a
 
 plays a
pivotal role in protein biosynthesis (Moldave, 1985). In ad-
dition, eEF-1
 
a
 
 is known to be involved in diverse cellular
processes, including embryogenesis (Krieg et al., 1989), se-
nescence (Shepherd et al., 1989), oncogenic transforma-
tion (Tatsuka et al., 1992), cell proliferation (Sanders et
al., 1996), and organization of the cytoskeleton (Condee-
lis, 1995; Edmonds et al., 1996). eEF-1
 
a
 
 is present mainly
in the cytoplasm of cells (Edmonds et al., 1996; Minella et
al., 1996), but a small population of eEF-1
 
a
 
 molecules has
been previously identified in the nucleus (Colling et al.,
1994; Janssen et al., 1994; Barberse et al., 1995; Billaut-
 
1. 
 
Abbreviations used in this paper:
 
 CBP, calmodulin-binding protein;
CT, COOH-terminal region of ZPR1; cZPR1, 
 
S
 
.
 
 cerevisiae
 
 ZPR1; DAPI,
4
 
9
 
6-diamidino-2-phenylindole; eEF-1
 
a
 
, eukaryotic translation elongation
factor-1
 
a
 
; GFP, green fluorescent protein; GST, glutathione-S-trans-
ferase; mZPR1, mouse ZPR1; NT, NH
 
2
 
-terminal region of ZPR1; PMA,
phorbol 12-myristate 13-acetate; PVDF, polyvinylene difluoride; pZPR1,
 
S
 
.
 
 pombe
 
 ZPR1.
 
Table I. Plasmids
 
Plasmids Description Source
 
YCp50
 
URA3
 
, 
 
ARS1
 
, 
 
CEN4
 
Rose et al., 1987
pRS317
 
LYS2
 
, 
 
ARSH4
 
, 
 
CEN6
 
Sikorski and Boeke, 1991
pRS405
 
LEU2
 
Sikorski and Hieter, 1989
pRS426
 
URA3
 
, 2 
 
m
 
Christianson et al., 1992
p413ADH
 
HIS3
 
, 
 
ARSH4
 
, 
 
CEN6
 
 with 
 
ADH
 
 promoter American Type Culture Collection
pLG1 YCp50 with genomic c
 
ZPR1
 
This study
pLG2 pBS with c
 
ZPR1
 
This study
pLP1 pGEX-3X with c
 
ZPR1
 
This study
pLP2 pGEX-5X-1 with 
 
TEF1
 
This study
pLP3 pCAL-n with c
 
ZPR1
 
This study
pLP4 pCAL-n with m
 
ZPR1
 
 (1—774) This study
pLPNT pCAL-n with c
 
ZPR1
 
 (1—780) This study
pLPCT pCAL-n with c
 
ZPR1
 
 (781—1,458) This study
pLPD1 pCAL-n with c
 
ZPR1
 
 
 
D
 
 (664—723) This study
pLPD2 pCAL-n with c
 
ZPR1
 
 
 
D
 
 (664—783) This study
pLDP3 pCAL-n with c
 
ZPR1
 
 
 
D
 
 (604—723) This study
pLDP4 pCAL-n with c
 
ZPR1
 
 
 
D
 
 (604—783) This study
pLPD5 pCAL-n with c
 
ZPR1
 
 
 
D
 
 (604—663) This study
pLC1 p413ADH with c
 
ZPR1
 
This study
pLCNT p413ADH with c
 
ZPR1
 
 (1—780) This study
pLCCT p413ADH with c
 
ZPR1
 
 (781—1,458) This study
pLCCT2 pRS317 with 
 
ADH
 
 promoter, c
 
ZPR1
 
 (781—1,458) This study
pLCD1 p413ADH with c
 
ZPR1
 
 
 
D
 
 (664—723) This study
pLCD2 p413ADH with c
 
ZPR1
 
 
 
D
 
 (664—783) This study
pLCD3 p413ADH with c
 
ZPR1
 
 
 
D
 
 (604—723) This study
pLCD4 p413ADH with c
 
ZPR1
 
 
 
D
 
 (604—783) This study
pLCD5 p413ADH with c
 
ZPR1
 
 
 
D
 
 (604—663) This study
pLCNT2 p413ADH with c
 
ZPR1
 
 (1—780) 
 
D
 
 (604—663) This study
pLCG1 p413ADH with c
 
ZPR1
 
 
 
D
 
 (604—663), 
 
GFP
 
This study
pLCG2 p413ADH with c
 
ZPR1
 
 (1—780), 
 
GFP
 
This study
pLCG3 p413ADH with c
 
ZPR1
 
 (781—1,485), 
 
GFP
 
This study
pMM6 pRS405 with c
 
ZPR1
 
 (
 
2
 
785 to 
 
2
 
10), (970—1,471) This study
pMM13 pRS426 with 
 
GAL
 
 promoter, c
 
ZPR1
 
This study
pMM29 p413ADH with c
 
ZPR1
 
 (294, 297 C/A) This study
pMM36 p413ADH with c
 
ZPR1
 
 (54, 57 C/A) This study
pMM38 pRS317 with 
 
ADH
 
 promoter, c
 
ZPR1
 
 (1—780) This study
pMM48 p413ADH with 
 
GFP
 
This study
pMM49 p413ADH with c
 
ZPR1
 
, 
 
GFP
 
This study
pZPP pGEX-3X with p
 
ZPR1
 
This study
pLZM1—7 pGEX-5X-1 with m
 
ZPR1
 
 (fragments 1—7) Galcheva-Gargova et al., 1996
pZM2 pCDNA3 with Flag-m
 
ZPR1
 
Galcheva-Gargova et al., 1996
pZPM pGEX-3X with m
 
ZPR1
 
Galcheva-Gargova et al., 1996
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Mulot et al., 1996; Sanders et al., 1996). Recently, eEF-1
 
a
 
was shown to bind viral RNA (Blackwell and Brinton,
1997) and RNA polymerases (Blumenthal and Carmi-
chael, 1979; Das et al., 1998).
The involvement of eEF-1
 
a
 
 in nuclear processes re-
mains to be established. The results of the present study
suggest that the physiological functions of eEF-1
 
a
 
 in the
nucleus may include complex formation with ZPR1 in mi-
togen-treated cells.
 
Materials and Methods
 
Preparation of Recombinant Plasmids and Proteins
 
The yeast 
 
ZPR1
 
 gene was isolated by screening an 
 
S
 
.
 
 cerevisiae genomic
library (prepared by Rose et al., 1987) using colony screening. A 300-bp
fragment, amplified using the polymerase chain reaction (PCR), from the
right arm of chromosome VII of S. cerevisiae was used for preparing the
[32P]labeled probe for hybridization (Prime-It II; Stratagene, La Jolla,
CA). Positive clones were examined by automated sequencing (model
373A; Applied Biosystems, Foster City, CA). The S. pombe zpr11 gene
was isolated using a similar procedure (Galcheva-Gargova et al., 1998).
Subsequently, the open reading frame encoding S. cerevisiae ZPR1
(YGR211w) was identified in the S. cerevisiae genome (GenBank/EMBL/
DDBJ accession number Z72996). The nucleotide sequence of the cloned
ZPR1 gene and YGR211w were identical. Standard recombinant DNA
techniques were used to construct fusion proteins. The coding region of S.
cerevisiae ZPR1 (cZPR1) was amplified by PCR with the cZPR1 genomic
clone (pLG1) as the template and was subcloned in the plasmid pBS
(Stratagene) as an XhoI fragment at the SalI site (pLG2). This cZPR1
fragment was cloned as an XhoI (blunt-ended)-EcoRI fragment (from
pLG2) in pGEX-3X (Pharmacia Biotech, Piscataway, NJ) at the SmaI/
EcoRI sites. Full-length (wild-type) and truncated cZPR1, amplified by
PCR, were cloned in pCAL-n (Stratagene) and p413ADH (American
Type Culture Collection, Rockville, MD) expression vectors at the SmaI/
EcoRI sites. Mouse ZPR1 (mZPR1), full-length and truncated fragments
amplified by PCR, were cloned in pCAL-n at the EcoRI/XhoI sites.
S. pombe ZPR1 (pZPR1) was PCR amplified and cloned in pGEX-3X at
the BamHI/EcoRI sites. Mutant green fluorescent protein (GFP) (S65T,
V163A; Anderson et al., 1996) was PCR amplified and cloned in p413
ADH at the SmaI/EcoRI sites to create the plasmid pMM48. A cZPR1
fragment (BglII-SmaI) amplified by PCR was cloned in pMM48 at the
BamHI/SmaI sites to create the plasmid pMM49. The S. cerevisiae gene
encoding translation elongation factor eEF-1a (TEF1) was amplified by
PCR using genomic DNA as the template and was cloned into pGEX-5X-1
(Pharmacia Biotech) at the BamHI site. In-frame deletions were prepared
using standard PCR-based procedures. The plasmids used in this study are
summarized in Table I.
Recombinant plasmids that express fusion proteins with calmodulin-
binding protein (CBP) and glutathione-S-transferase (GST) were ex-
pressed in BL21 (DE3) bacteria and BL21 bacteria, respectively. The
fusion proteins were induced with 1 mM IPTG for 2 h at 308C and were
purified by affinity chromatography.
Disruption of the ZPR1 Gene
Yeast were manipulated according to standard procedures. The diploid
strain (MY2) heterozygous for the ZPR1 gene disruption was constructed
using established techniques (Rothstein, 1993). The recombinant plasmid
pMM6 was prepared by inserting two fragments of the cZPR1 gene (2785
bp to 210 bp and 1970 bp to 11,471 bp) flanking the LEU2 gene in the
plasmid pRS405 (Sikorski and Hieter, 1989). The ScaI-SpeI fragment
from pMM6 containing the disrupted cZPR1 gene was transformed into
the diploid yeast strain CY246 (obtained from C.L. Peterson, University
of Massachusetts Medical School, Worcester, MA). Southern blots of the
Leu1 transformants identified colonies heterozygous for the cZPR1 dis-
ruption. The heterozygote MY2 was sporulated and tetrads were dis-
sected. The spores showed 2:2 segregation of viability and none of the via-
ble spores were Leu1, indicating that the disruption of the cZPR1 gene
was lethal. To isolate haploid yeast with the cZPR1 disrupted gene (zpr1::
LEU2), yeast strain MY2 (diploid) was transformed with the plasmid
pMM13 (ZPR1 under control of the GAL promoter on a URA1 plasmid),
sporulated, and then tetrads were dissected. Leu1 Ura1 haploid cells
(zpr1::LEU2) complemented with wild-type cZPR1 on plasmid pMM13
were selected and designated as strain MY7. Mutant cZPR1 genes were
introduced into strain MY7 by plasmid shuffling (Sikorski and Boeke,
1991) using 59-fluoroorotic acid (Toronto Research Chemicals, North
York, Ontario, Canada). Yeast strains with wild-type and mutant cZPR1
are listed in Table II.
Mammalian Cell Culture
COS-7 and A431 cells were maintained in DulbeccoÕs modified EagleÕs
Table II. Saccharomyces cerevisiae Strains
Strain Genotype Source
L40 MATa his3D200 trp1-901 leu2-3,112 ade2 LYS2:: (lexAop)4-His URA3::(lexAop)8-LacZ Vojtek et al., 1993
CY246 MATa/MATa lys2-801/lys2-801 ade2-101/ade2-101 leu2-D1/leu2-D1 his3-D200/his3-D200 ura3-D99/ura3-D99 C.L. Peterson, 
University of Massachusetts
Medical School,
Worcester, MA
MY2 MATa/MATa lys2-801/lys2-801 ade2-101/ade2-101 leu2-D1/leu2-D1/his3-D200/his3-D200 ura3-D99/ura3-D99 
zpr1::LEU2/ZPR1
This study
MY7 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pMM13 This study
MY28 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pMM49 This study
LY1 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLC1 This study
LY2 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD1 This study
LY3 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD2 This study
LY4 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD3 This study
LY5 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD4 This study
LY6 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD5 This study
LY7 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD3, pMM38 This study
LY8 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCD5, pMM38 This study
LY9 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCCT This study
LY10 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCCT, pMM38 This study
LY11 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCG1 This study
LY12 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pMM13, pLCG2 This study
LY13 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCCT2, pLCNT2 This study
LY14 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pLCG3, pMM38 This study
MY17 MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99 zpr1::LEU2 pMM36 This study
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medium, 2 mM glutamine, 100 U/ml penicillin and 100 U/ml streptomycin
supplemented with 10% heat-inactivated fetal bovine serum (COS-7 cells)
or 5% calf serum (A431 cells) (Life Technologies, Gaithersburg, MD).
The cells were grown at 378C in a humidified atmosphere with 5% CO2.
Transfection with the plasmid pCDNA3-Flag-mZPR1 (Galcheva-Gar-
gova et al., 1996) was performed using Lipofectamine (Life Technologies)
according to the manufacturerÕs instructions. A431 cells were grown to
50—60% confluence and starved in serum-free medium for 24 h. The cells
were treated with 100 nM EGF or PMA for 5—60 min at 378C.
Binding Assays
Binding assays were performed using CBP and GST fusions with [35S]me-
thionine-labeled and -unlabeled cell lysates. The cell extracts were pre-
pared with lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 mM
b-mercaptoethanol, 1.0 mM MgCl2, 1.0 mM CaCl2, 1.0 mM imidazole,
0.1% Triton X-100, 1.0 mM PMSF, 1.0 mM benzamidine, 1 mM sodium
orthovanadate, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml bestatin,
10 mg/ml antipain, 1.0 mg/ml pepstatin A, and 1.0 mg/ml chymostatin).
CBP and GST fusions (5 mg) were immobilized on calmodulin affinity
resin (Stratagene) and glutathione agarose beads (Pharmacia Biotech), re-
spectively. The beads (20 ml) were washed twice at 48C and incubated with
cell extracts (300—500 mg protein) for 2 h in 500 ml lysis buffer at 48C and
then washed three times. The beads were boiled with Laemmli sample
buffer for 3 min, centrifuged, and then the supernatant was examined by
SDS-PAGE.
Mass Spectroscopy
A 50-kD ZPR1 binding protein was purified from human A431 epider-
moid carcinoma cells and S. cerevisiae strain L40 by affinity chromatogra-
phy using immobilized CBP-ZPR1 (residues 1—268). Bound proteins were
separated by SDS-PAGE and electrotransferred to a polyvinylene di-
fluoride (PVDF) membrane (Applied Biosystems). The membrane was
stained with Ponceau S and the 50-kD protein was excised, rinsed with
water, and then air dried. The protein was digested with l-tosylamido-
2-phenyl ethyl chloromethyl ketone-treated trypsin and subjected to mass
spectroscopic analysis using the matrix-assisted laser desorption ioniza-
tion with time of flight (MALDI-TOF) technique. Masses of the poly-
peptides obtained were compared with the MS-Fit data base (Ludwig
Institute for Cancer Research and University College London mass spec-
troscopy facility, London, UK).
Immunoprecipitation and Immunoblotting
Cell extracts prepared using Triton lysis buffer (20 mM Tris-HCl, pH 7.4,
137 mM NaCl, 2 mM EDTA, 25 mM b-glycerophosphate, 2 mM sodium
pyrophosphate, 1% Triton X-100, 10% glycerol, 1 mM PMSF, 1 mM so-
dium orthovanadate, 10 mg/ml leupeptin, and 10 mg/ml aprotinin) were
used for immunoprecipitation studies. Antibodies to mouse ZPR1 (Gal-
cheva-Gargova et al., 1996), eEF-1a (Upstate Biotechnology, Lake Placid,
NY) and Flag (M2; Eastman-Kodak, Rochester, NY) were prebound to
20 ml of protein A—Sepharose (Pharmacia Biotech). The beads were incu-
bated with cell lysate for 2 h, washed three times, and then boiled with
Laemmli sample buffer before gel electrophoresis. Bound proteins sepa-
rated by SDS-PAGE (10%) were electrotransferred to PVDF membranes
(0.45 mm; Millipore, Waters Chromatography, Milford, MA). Antibody
incubations were carried out in Tris-buffered saline with 0.5% Tween-20
and 20% horse serum. The rabbit anti-ZPR1 and mouse anti—eEF-1a an-
tibodies were diluted 1:400 and 1:1,000, respectively. HRP-conjugated
donkey anti—rabbit IgG and sheep anti—mouse IgG (1:5,000) secondary
antibodies were detected by enhanced chemiluminescence (Amersham
International, Little Chalfont, UK).
Fluorescence Microscopy
A431 cells were cultured on glass coverslips coated with poly-l-lysine. The
cells were incubated in serum-free medium for 24 h, starved, and then
treated with 100 nM EGF or PMA at 378C for 15 min. Coverslips were
rinsed with phosphate-buffered saline (PBS) and then briefly with chilled
methanol. The cells were fixed at 2208C with methanol for 5 min, and
then with acetone for 2 min. The coverslips were blocked with 10% horse
serum in PBS with 0.5% Tween-20 (PBS-T) for 30 min at 258C in Coplin
jars and then incubated with primary antibodies for 1 h at 258C. The rabbit
polyclonal antibody to ZPR1 has been described (Galcheva-Gargova et
al., 1996). The mouse monoclonal antibody to eEF-1a was purchased
from Upstate Biotechnology. The cells were washed with PBS-T (0.2%
Tween-20) three times and incubated with conjugated secondary anti-
bodies (goat cyanine [Cy3]-labeled anti-rabbit IgG and goat fluorescein
[FITC]-labeled anti-mouse IgG; Jackson ImmunoResearch Laboratories,
West Grove, PA) for 1 h and washed three times with PBS-T (0.2%
Tween-20). Coverslips were mounted on slides using Vectashield (Vector
Laboratories, Burlingame, CA) and examined by double-label immuno-
fluorescence microscopy using a conventional microscope (Carl Zeiss Inc.,
Thornwood, NY).
Haploid yeast cells with the disrupted zpr1::LEU2 gene were trans-
formed with plasmids expressing wild-type cZPR1, mutated cZPR1, or
cZPR1 fusion proteins with GFP. Cells were grown in synthetic media
with glucose (2%). Log-phase cultures were diluted (0.5 OD600) and
starved in glucose-free medium for 12 h at 308C. Glucose (2%) was added
and the cells were incubated at 308C for 2 h. The cells were harvested and
stained with 496-diamidino-2-phenylindole (DAPI). The GFP and DAPI
fluorescence was examined by conventional microscopy (Carl Zeiss Inc.).
Image analysis was performed using the computer software NIH Image
(v 1.61/PPC; Bethesda, MD).
Flow Cytometry
Samples were prepared for flow cytometry (Lew et al., 1992). Cells (106)
were pelleted, washed twice with PBS, resuspended in 100 ml PBS, and
then added dropwise into 70% ethanol (1.5 ml) with vortexing. The cells
were fixed overnight in 70% ethanol at 48C, washed with PBS, and then
digested with 1 mg/ml RNase in 50 mM Tris-HCl, pH 8.0, for 1 h at 378C
followed by 5 mg/ml pepsin in 55 mM HCl for 30 min at 378C. The cells
were washed with PBS, stained with propidium iodide, and then analyzed.
Results
The Zinc Finger Protein ZPR1 Is Conserved in 
Mammals and Yeast
Homologues of the mammalian zinc finger protein ZPR1
were identified and cloned from the yeast S. cerevisiae and
Schizosaccharomyces pombe. The sequence of the mouse,
S. cerevisiae and S. pombe ZPR1 proteins was deduced
from the nucleotide sequence of DNA clones (Fig. 1 A).
Comparison of these ZPR1 proteins indicates a conserved
structure including two similar zinc fingers (ZnF1 and
ZnF2) and similar regions after each zinc finger (Fig. 1 B,
A and B). The mouse ZPR1 (mZPR1) protein is 46%
identical and 72% similar to S. cerevisiae ZPR1 (cZPR1)
and 43% identical and 70% similar to S. pombe ZPR1
(pZPR1). The two yeast proteins are 55% identical and
78% similar. The high level of homology between yeast
and mammalian ZPR1 suggests that the overall structure
of the protein is conserved between lower and higher eu-
karyotes.
ZPR1 Is an Essential Gene in S. cerevisiae
We examined whether the gene encoding cZPR1 was es-
sential for cell viability in S. cerevisiae. A DNA fragment
containing the cZPR1 gene disrupted by the LEU2 gene
(Fig. 2 A) was transformed into the diploid yeast strain
CY246. Colonies were selected on plates lacking leucine
and the disruption of one genomic copy of cZPR1 was
confirmed by Southern blot analysis (Fig. 2 B). The dip-
loid yeast strain MY2, which is heterozygous for wild-type
cZPR1 (ZPR1/zpr1::LEU2), was sporulated and the tet-
rads were dissected. In all tetrads analyzed, the viable
progeny segregated 2:2, and none of the surviving spores
were Leu1 (disrupted for cZPR1). These data indicate
that the cZPR1 gene is essential for viability (Fig. 2 C). To
establish that the loss of viability was due to the disruption
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of the cZPR1 gene, we complemented haploid yeast with
the disrupted cZPR1 gene (zpr1::LEU2) using a plasmid
expressing wild-type cZPR1. These data demonstrated
that the cZPR1 gene was essential for viability in S. cerevi-
siae.
Identification of eEF-1a as a ZPR1-binding Protein
To study the interaction of ZPR1 with other proteins, we
performed in vitro binding assays using [35S]methionine
human A431 epidermoid carcinoma cell extracts and im-
mobilized GST—ZPR1 fusion proteins. As expected, the
mouse ZPR1 protein bound to the 180-kD EGF receptor
(Fig. 3 A). In addition, several other [35S]methionine pro-
teins were observed to bind ZPR1. In particular, a 50-kD
protein was prominently detected in binding assays using
mouse, S. cerevisiae and S. pombe ZPR1 proteins (Fig. 3
A). Similar results were obtained in binding assays using
[35S]methionine extracts prepared from COS-7, CHO, and
S. cerevisiae (strain L40) cells (data not shown). These
data indicate that the yeast and mammalian ZPR1 pro-
teins may have similar biochemical properties, including
interaction with a 50-kD protein.
Deletion analysis of mouse ZPR1 using [35S]methionine
cell extracts demonstrated that an NH2-terminal mZPR1
fragment (ZnF1-A; residues 1—268) was sufficient for bind-
ing the 50-kD protein (data not shown). This fragment of
mZPR1 was used to isolate the 50-kD protein from human
(A431) and S. cerevisiae (L40) cell extracts by affinity
chromatography. The bound proteins were resolved by
SDS-PAGE and electrotransferred onto a PVDF mem-
brane. The 50-kD protein was digested with l-tosylamido-
2-phenyl ethyl chloromethyl ketone-treated trypsin and
examined by mass spectroscopy using the MALDI-TOF
technique. A comparison of the masses of the polypep-
tides obtained with the MS-Fit data base led to the identi-
fication of the 50-kD protein as eEF-1a (Table III).
To confirm the identification of the 50-kD protein as
eEF-1a, we examined the proteins that bound to mZPR1
by Western blot analysis using an antibody to eEF-1a. Im-
mobilized recombinant mZPR1 was found to bind eEF-1a
(Fig. 3 B, lane 8). Similarly, immobilized recombinant
eEF-1a bound to mZPR1 (Fig. 3 C). Deletion analysis
Figure 1. Identification of ZPR1 homologues in mammals and
yeast. (A) The sequence of the S. cerevisiae, S. pombe, and mouse
ZPR1 proteins deduced from the nucleotide sequence of DNA
clones is presented. Residues identical to the sequence of mouse
ZPR1 are indicated with a period (.). Gaps were introduced into
the sequences to optimize the alignment (-). Overline, zinc fin-
gers; asterisks, Cys residues. The sequences of mouse ZPR1, S.
pombe zpr1 and S. cerevisiae ZPR1 have been deposited with
GenBank/EMBL/DDBJ accession numbers U41287, AF019768
and AF019769, respectively. (B) Schematic representation of the
predicted domain structure of ZPR1. The regions required for in-
teraction with the EGF receptor are indicated (EGF-R).
Figure 2. ZPR1 is an essential gene in the yeast S. cerevisiae. (A)
The S. cerevisiae diploid WT strain (CY246) was used to create
the heterozygous strain MY2 (ZPR1/zpr1::LEU2). The struc-
tures of the wild-type and disrupted cZPR1 genes are illustrated.
(B) Disruption of one ZPR1 allele was confirmed by Southern
blot analysis of PvuI restricted genomic DNA isolated from the
diploid WT strain CY246 and the heterozygous strain MY2
(ZPR1/zpr1::LEU2). (C) The heterozygous diploid strain MY2
(ZPR1/zpr1::LEU2) was sporulated and eight randomly selected
asci were dissected and examined for viability on YEPD agar
media.
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demonstrated that the NH2-terminal region of mZPR1
was sufficient for binding eEF-1a (Fig. 3 B). Deletion
analysis of eEF-1a demonstrated that the NH2-terminal
region (residues 1—300) was required for binding ZPR1
(data not shown). To test whether ZPR1 and eEF-1a bind
directly, we performed in vitro assays using the two puri-
fied recombinant proteins. This analysis demonstrated
that eEF-1a directly binds to cZPR1 (Fig. 3 D).
Figure 3. ZPR1 binds to eEF-
1a in vitro. (A) A431 cells
were labeled with [35S]me-
thionine. Soluble extracts
were prepared and incubated
with immobilized ZPR1
(GST—ZPR1) proteins from
three species: S. cerevisiae, S.
pombe, and mouse. Bound
proteins were examined by
SDS-PAGE and autoradiog-
raphy. Arrows, binding of the
180-kD EGF receptor to
mouse ZPR1 and the promi-
nent 50-kD protein that binds
to mouse and yeast ZPR1
proteins. (B) Deletion analy-
sis of mZPR1 sequences re-
quired for interaction with
eEF-1a. Immobilized GST
and GST—mZPR1 fusion pro-
teins were incubated with cell
lysates. Bound eEF-1a was
detected by protein immunoblot analysis using a monoclonal antibody to eEF-1a. The binding of eEF-1a to full-length (lane 8) and
truncated (lanes 1—7) mZPR1 proteins is presented. The mZPR1 amino acid residues in the truncated constructs are: 1—99 (1); 94—268
(2); 263—306 (3); 302—469 (4); 1—268 (5); 263—469 (6); 1—306 (7); and 1—469 (8). (C) Recombinant eEF-1a binds to mZPR1 in vitro. Im-
mobilized GST and GST—eEF-1a were incubated with cell lysates. Bound mZPR1 was detected by protein immunoblot analysis using a
rabbit polyclonal antibody to mZPR1. The multiple bands are characteristic of the electrophoretic mobility of mZPR1 (Galcheva-Gar-
gova et al., 1996). (D) Binding of recombinant eEF-1a and cZPR1. Immobilized GST and GST—eEF-1a were incubated with purified
CBP—cZPR1. Bound cZPR1 was detected by protein immunoblot analysis.
Table III. Identification of the 50-kD ZPR1-binding Protein by Mass Spectroscopy
Mass submitted Mass matched Peptide sequences Protein matched
Saccharomyces cerevisiae
1026.0000 1026.2286 (K) IGGIGTVPVGR (V)
1494.0000 1492.7675 (K) YAWVLDKLKAER (E)
1563.0000 1561.7876 (K) SHINVVVIGHVDSGK (S)
1861.0000 1860.1303 (K) YQVTVIDAPGHRDFIK (N)
2326.0000 2326.7513 (K) FVPSKPMCVEAFSEYPPLGR (F) eEF-1a
(50032.9 kD)2365.0000 2364.7137 (K) TLLEAIDAIEQPSRPTDKKPLR (L)
2432.0000 2431.9076 (R) VETGVIKPGMVVTFAPAGVTTEVK (S)
2552.0000 2551.8068 (K) SVEMHHEQLEQGVPGDNVGFNVK (N)
2911.0000 2910.2887 (K) TVPFVPISGWNGDNMIEATTNAPWYK (G)
3320.0000 3321.8552 (K) TLLEAIDAIEQPSRPTDKPLRLPLQDVYK (I)
Human
815.6000 816.9392 (K) EKIDRR (S)
959.0000 960.1287 (K) IDRRSGKK (L)
959.0000 960.1256 (K) SAQKAQKAK (—)
1026.0000 1026.2286 (K) IGGIGTVPVGR (V)
1121.0000 1121.2830 (K) STTTGHLIYK (C) eEF-1a
(50127.1 kD)1315.5000 1314.5320 (K) GSFKYAWVLDK (L)
1315.5000 1315.5608 (R) EHALLAYTLGVK (Q)
1405.8000 1405.6019 (K) YYVTIIDAPGHR (D)
1405.8000 1405.6461 (K) FAELKEKIDRR (S)
1590.3000 1589.8416 (K) THINIVVIGHVDSGK (S)
2517.6001 2517.0136 (R) VETGVLKPGMVVTFAPVNVTTEVK (S)
3011.8000 3011.4769 (R) KSGDAIVDMVPGKPMCVESPSDYPPLGR (F)
The 50-kD protein was purified by affinity chromatography and SDS-PAGE. The protein was electroblotted onto a PVDF membrane, digested with L-tosylamido-2-phenyl ethyl
chloromethyl ketone-treated trypsin, and then subjected to mass spectroscopy using the MALDI-TOF technique. Peptide masses obtained were compared with the MS-Fit data-
base.
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Interaction of eEF-1a and ZPR1 In Vivo
To test whether eEF-1a and ZPR1 may interact in vivo,
we performed coimmunoprecipitation analysis. Epitope-
tagged mZPR1 was immunoprecipitated from serum-
treated COS-7 cells and the presence of eEF-1a in the im-
munoprecipitates was examined by Western blot analysis.
Fig. 4 A shows that eEF-1a was coimmunoprecipitated
with ZPR1. Control experiments using cells that did not
express epitope-tagged mZPR1 demonstrated no coimmu-
noprecipitation of eEF-1a. These data indicate that ZPR1
and eEF-1a may interact in vivo.
ZPR1 has been shown to bind the EGF receptor in qui-
escent cells and to be released from the receptor upon
treatment with EGF (Galcheva-Gargova et al. 1996). EGF
may therefore regulate the interaction of ZPR1 with eEF-
1a. To examine the effect of EGF, we starved A431 cells
in serum-free medium for 24 h and then treated the cells
with 100 nM EGF. eEF-1a was immunoprecipitated and
the presence of ZPR1 was detected by Western blot analy-
sis. Coimmunoprecipitation of ZPR1 with eEF-1a was
detected in the EGF-treated cells, but not in the serum-
starved cells (Fig. 4 B). The amount of coimmunoprecipi-
tated ZPR1 was sustained during longer periods of treat-
ment with EGF (Fig. 4 C). These data indicate that EGF
induces an interaction between ZPR1 and eEF-1a. To test
whether this interaction between ZPR1 and eEF-1a can
be induced by other stimuli, we studied the effect of serum.
Treatment of serum-starved cells with fetal calf serum
(10%) resulted in the coimmunoprecipitation of ZPR1
with eEF-1a (Fig. 4, B and C). Based on these observa-
tions, we propose that growth signals in mitogen-activated
cells may induce the formation of eEF-1a/ZPR1 com-
plexes in vivo. Specificity in the formation of the eEF-1a/
ZPR1 complex was established by the observation that
treatment of the cells with the tumor promoter phorbol
12-myristate 13-acetate (PMA) did not cause coimmuno-
precipitation of ZPR1 with eEF-1a (Fig. 4 B).
Redistribution of ZPR1 and eEF-1a to the Nucleus of 
Mitogen-activated Mammalian Cells
We examined the subcellular localization of ZPR1 and
eEF-1a in mammalian cells by double-label immunofluo-
rescence microscopy. Consistent with previous studies
(Galcheva-Gargova et al., 1996) we observed that ZPR1
(red) redistributed from the cytoplasm to the nucleus upon
EGF stimulation of serum-starved cells (Fig. 5). eEF-1a is
an abundant protein that is present mainly in the cyto-
plasm of cells (Edmonds et al., 1996). Fig. 5 shows the
effect of EGF treatment on the subcellular distribution
of eEF-1a (green). In serum-starved cells, eEF-1a was
present in the cytoplasm. Upon treatment with EGF, a
fraction of the eEF-1a molecules was observed to redis-
tribute from the cytoplasm to the nucleus. The distribution
of eEF-1a and ZPR1 in the nucleus after treatment of cells
with EGF was similar, as represented by yellow fluores-
cence in the merged images of ZPR1 and eEF-1a (Fig. 5).
Similar results were obtained upon treatment of serum-
starved cells with 10% calf serum (data not shown). Quan-
titative analysis of the fluorescence images demonstrated
that ZPR1 was z98% cytoplasmic in serum-starved cells
and was z96% nuclear in EGF-treated cells. Similar anal-
ysis demonstrated that eEF-1a was not detected in the nu-
cleus of serum-starved cells and that z5% of the total
eEF-1a was located in the nucleus after stimulation with
EGF. These data indicate that both ZPR1 and eEF-1a are
located in the nucleus of mitogen-treated cells. The punc-
tate distribution of ZPR1 in the nucleus was previously
Figure 4. Coimmunoprecipitation analysis demonstrates that
eEF-1a and ZPR1 interact in vivo. (A) COS-7 cells were mock-
transfected (CONTROL) or transfected with a vector expressing
epitope-tagged ZPR1. Flag-ZPR1 was immunoprecipitated with
the M2 monoclonal antibody. eEF-1a in the immunoprecipitates
(IP) was detected by protein immunoblot analysis with a mono-
clonal antibody to eEF-1a. (B) Coimmunoprecipitation of ZPR1
with eEF-1a from cells treated with serum or EGF. A431 epider-
moid carcinoma cells were incubated in serum-free medium for
24 h. The cells were untreated or treated with 5% calf serum, 100
nM EGF, or 100 nM PMA for 15 min. Extracts were prepared
from the cells and eEF-1a was isolated by immunoprecipitation.
Specificity of the immunoprecipitation was examined using mock
immunoprecipitates prepared using protein A—Sepharose beads
without antibody to eEF-1a (CONTROL). ZPR1 in the immuno-
precipitates was detected by protein immunoblot analysis using a
rabbit polyclonal antibody. (C) EGF causes the rapid formation
of ZPR1/eEF-1a complexes that are detected by coimmunopre-
cipitation analysis. A431 cells were serum starved for 24 h. The
cells were incubated with 100 nM EGF for various times, extracts
were prepared, and then eEF-1a was isolated by immunopre-
cipitation. Specificity of the immunoprecipitation was examined
using mock immunoprecipitates prepared using protein A—Seph-
arose beads without antibody to eEF-1a (CONTROL). The pres-
ence of ZPR1 in the immunoprecipitates was examined by pro-
tein immunoblot analysis with a rabbit polyclonal antibody. 
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demonstrated to correspond to an accumulation within
nucleoli (Galcheva-Gargova et al., 1996). This nucleolar
accumulation is characterized by colocalization of ZPR1
with fibrillarin and RNA polymerase I, but not with splic-
ing factor SC35 or p80 coilin (Galcheva-Gargova et al.,
1998).
We studied the effect of PMA on the subcellular distri-
bution of eEF-1a and ZPR1 to confirm the specificity of
the interaction between eEF-1a and ZPR1 in the response
to extracellular stimulation. PMA is known to induce the
phosphorylation of eEF-1a by activating protein kinase C
(Venema et al., 1991). However, PMA did not cause punc-
tate nuclear accumulation of eEF-1a or ZPR1 (Fig. 5).
These data are consistent with the results of coimmuno-
precipitation analysis where treatment with PMA did not
induce the formation of ZPR1/eEF-1a complexes (Fig. 4
B). We conclude that ZPR1 responds to selective extracel-
lular stimuli.
Nuclear Redistribution of ZPR1 in Yeast
To study the localization of cZPR1 in the yeast S. cerevi-
Figure 5. Redistribution of
eEF-1a and ZPR1 from the
cytoplasm to the nucleus in
EGF-treated cells. A431
cells were incubated in se-
rum-free medium for 24 h
(starved) and then treated
with 100 nM EGF or 100 nM
PMA for 15 min at 378C. The
cells were fixed, permeabi-
lized, and then examined by
double-label immunofluores-
cence microscopy. Fluores-
cein (green) and cyanine
(red) represent eEF-1a and
ZPR1, respectively. Yellow,
colocalization of eEF-1a and
ZPR1 in the nucleus upon
EGF treatment in merged
images. Bar, 50 mm.
Figure 6. Redistribution of
ZPR1 in the yeast S. cerevi-
siae. The haploid yeast strain
MY28 (Table III) examined
by fluorescence microscopy.
This yeast strain expresses
cZPR1—GFP in the absence
of wild-type cZPR1. The cells
were grown in synthetic me-
dium with glucose (CON-
TROL) and starved in glu-
cose-free medium for 12 h
(STARVED). Glucose (2%)
was added to the starved cells
and incubated for 2 h (GLU-
COSE). The GFP (green)
and DAPI (blue) represents
ZPR1 and DNA, respec-
tively. Bar, 10 mm.
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siae, a recombinant cZPR1—GFP fusion gene was con-
structed. The cZPR1—GFP gene complemented the loss of
viability of yeast with the disrupted zpr1::LEU2 gene.
These haploid yeast expressing the cZPR1—GFP fusion
protein were examined by fluorescence microscopy. Con-
trol experiments demonstrated that GFP was sequestered
in the vacuole of yeast expressing GFP alone (data not
shown). Fig. 6 shows that the cZPR1—GFP fusion protein
(green) was present mainly in the nucleus of S. cerevisiae
(CONTROL). Starvation of the yeast in glucose-free me-
dium caused the redistribution of cZPR1 from the nucleus
to the cytoplasm (Fig. 6). Readdition of glucose to the
starved cells induced the translocation of cZPR1 from the
cytoplasm to the nucleus. The localization and redistribu-
tion of ZPR1 in response to nutrients in S. cerevisiae ap-
pears to be similar to that observed in starved and mito-
gen-treated mammalian cells. Therefore, it is possible that
cZPR1 may function as a signaling molecule in S. cerevi-
siae that responds to proliferation signals.
Identification of Mutant ZPR1 Molecules That Fail to 
Interact with eEF-1a
To examine the interaction of ZPR1 with eEF-1a, we per-
formed deletion analysis of cZPR1. Studies using NH2-ter-
minal (NT) and COOH-terminal (CT) fragments of cZPR1
demonstrated that the eEF-1a—binding site was located in
the NH2-terminal region of cZPR1 (residues 1—261) (Fig.
7, A and B). We constructed a series of COOH-terminal
truncated mutants of the NT fragment of cZPR1. Binding
assays indicated that cZPR1 residues 202—261 were re-
quired for the interaction of eEF-1a with cZPR1 (data not
shown). Subsequently, a series of in-frame deletion mu-
tants of full-length cZPR1 (D1-D4) was prepared (Fig. 7
A). These internal deletion mutants were expressed as
CBP fusions in bacteria and purified. The binding of
eEF-1a to these cZPR1 proteins was detected by immuno-
blot analysis. The in-frame deletions D1 (residues 222—
241) and D2 (residues 222—261) had no effect on eEF-1a
binding, whereas deletions D3 (residues 202—241) and D4
(residues 202—261) eliminated the binding of eEF-1a to
cZPR1 (Fig. 7 C). These data suggest that a sequence re-
quired for eEF-1a binding is present in the D3 region (res-
idues 202—241) of cZPR1 (Fig. 7 A). To further delineate
the cZPR1 sequence required for the binding of eEF-1a,
the smaller in-frame deletion mutant D5 (residues 202—
221) was prepared and tested for eEF-1a binding. Immuno-
blot analysis demonstrated that the cZPR1 deletion
mutant D5 did not bind eEF-1a (Fig. 7 D). Therefore, the
20-amino acid region D5 (residues 202—221) was required
to be present in full-length and truncated ZPR1 for eEF-
1a binding. This region is located within the A-domain of
the cZPR1 protein and is conserved in mouse, S. cerevisiae
and S. pombe (Fig. 7 A).
Mutational Analysis of ZPR1 Function
We examined the effect of cZPR1 mutations that disrupt
eEF-1a binding on the viability of S. cerevisiae. The in-
frame deletion mutants D1, D2, D3, D4, and D5 comple-
mented the loss of viability caused by the disruption of the
cZPR1 gene in S. cerevisiae (Table IV). These data indi-
cate that deletion of sequences required for eEF-1a bind-
Figure 7. A small region of ZPR1 is required for interaction with
eEF-1a in the yeast S. cerevisiae. (A) Schematic representation of
S. cerevisiae ZPR1. NH2-terminal (NT; residues 1—261) and
COOH-terminal (CT; residues 262—486) fragments of cZPR1 are
illustrated. In-frame deletions within the full-length cZPR1 pro-
tein were constructed: D1 (residues 222—241), D2 (residues 222—
261), D3 (residues 202—241), D4 (residues 202—261), and D5 (res-
idues 202—221). The sequence of the D5 region in mouse and
yeast ZPR1 proteins is illustrated. (B—D) Recombinant cZPR1
proteins were expressed as a CBP fusion protein in bacteria. The
CBP fusion proteins were purified, immobilized, and then used
for binding assays using cell lysates. Bound eEF-1a was detected
by protein immunoblot analysis. The binding of eEF-1a to NT
and CT fragments of cZPR1 was examined (B). The effect of in-
frame deletions (D1, D2, D3, and D4) of cZPR1 was investigated
(C). The effect of the D5 in-frame deletion mutation of cZPR1
was also examined (D).
 o
n
 July 8, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
 Published December 14, 1998
The Journal of Cell Biology, Volume 143, 1998 1480
ing did not affect the essential role of ZPR1 required for
viability. Therefore, the binding of cZPR1 to eEF-1a was
not required for viability of S. cerevisiae.
We performed deletion analysis to identify the region of
cZPR1 that was required for yeast viability. Expression of
an NT fragment of cZPR1 (residues 1—261), which in-
cludes the first zinc finger and the region required for in-
teraction with eEF-1a, did not confer viability (Table IV).
In contrast, expression of a CT fragment of cZPR1 (resi-
dues 262—486), which includes the second zinc finger and
does not interact with eEF-1a, was able to confer viability
(Table IV). These data demonstrate that the functions of
cZPR1 to bind eEF-1a and to confer viability are encoded
within separate regions of the cZPR1 gene. eEF-1a bind-
ing requires the NT fragment of cZPR1 and viability re-
quires the CT fragment of cZPR1.
To further examine the sequences present in the CT
fragment of cZPR1 that are required for viability, we ex-
amined the effect of mutations in the cZPR1 zinc fingers.
The zinc fingers were disrupted by replacing two of the
Cys residues with Ala. Mutation of zinc finger 1 (located in
the NT fragment of cZPR1) complemented the loss of via-
bility caused by disruption of the ZPR1 gene. In contrast,
mutation of the second zinc finger (present in the CT
region of cZPR1) did not confer viability in this assay (Ta-
ble IV). These data indicate that the sequences located in
CT that are required for viability include the second zinc
finger.
Interaction of ZPR1 with eEF-1a Is Required for 
Normal Growth
The interaction of cZPR1 with eEF-1a did not appear to
be essential for viability of the yeast S. cerevisiae (Table
IV). However, ZPR1 and eEF-1a interact in response to
extracellular growth stimuli (Fig. 4, B and C). Therefore, it
was possible that this interaction may play a role in the
normal process of cellular proliferation. To examine the
function of the ZPR1/eEF-1a complex in cellular growth,
we investigated the effect of cZPR1 mutations that disrupt
eEF-1a binding on the growth of S. cerevisiae. Control ex-
periments demonstrated that the cZPR1 mutants D1 and
D2, which bind eEF-1a, exhibited no growth defect (Fig. 8
A). In contrast, the yeast strains (Table II) expressing mu-
tant cZPR1 (D3, D5, and CT) proteins that do not bind
eEF-1a (Table IV) were found to grow at least 20-fold
slower than yeast expressing wild-type cZPR1 (Fig. 8, A
and B).
The morphology of the yeast strains expressing wild-
type and mutant cZPR1 proteins was examined by light
microscopy. Fig. 8 C shows images of yeast expressing
wild-type cZPR1 or mutant D5 cZPR1 that does not bind
eEF-1a. Cells with mutant cZPR1 (D5) are larger and
grow in chain-like clusters. The failure of the cells to sepa-
rate and their larger size suggest that these slow-growing
yeast may accumulate in the G2/M phase of the cell cycle.
These cells were therefore examined for DNA content by
flow cytometry. Fig. 8 C shows that the wild-type cells are
distributed between the G1 and G2 phases of the cell cy-
cle, corresponding to 1N and 2N DNA content, respec-
tively (Fig. 8 C). In contrast, the majority of the mutant
yeast cells contained 2N DNA (Fig. 8 D), consistent with
an accumulation in the G2/M phase of the cell cycle (Fig. 8
C). These data suggest that the interaction of cZPR1 with
eEF-1a may be required for normal cell cycle progression.
To examine whether the absence of binding to eEF-1a is
relevant to the defective growth of yeast strains that ex-
press mutant cZPR1 molecules (D3, D5, and CT), we per-
formed an interallelic complementation assay. The NT
fragment of cZPR1 binds eEF-1a, but is not sufficient for
viability. However, the expression of the NT fragment of
cZPR1 in the D3, D5, and CT mutant ZPR1 yeast strains
restored normal proliferation (Fig. 8, A and B). To con-
firm that the restoration of normal growth is due to the in-
teraction of ZPR1 with eEF-1a, a yeast strain expressing
the CT fragment was transformed with a plasmid express-
ing the NT (DD5) fragment of cZPR1 which does not bind
eEF-1a. Expression of NT (DD5) did not restore the growth
of the yeast complemented with the CT fragment of
cZPR1 (Fig. 8 B). These data are consistent with the hy-
pothesis that the interaction of cZPR1 with eEF-1a was
required for the normal growth of yeast. The specificity of
the D5 mutation to cause reduced growth was tested by
comparison with the effect of mutation of the first zinc fin-
ger of cZPR1 (replacement of two of the Cys residues with
Ala). Mutation of the first zinc finger caused slow growth
that was not associated with accumulation at the G2/M
phase of the cell cycle (data not shown). Thus, the G2/M ac-
cumulation caused by the D5 mutation does not represent
a nonspecific consequence of defects in cZPR1 function.
To further examine the effect of the NT fragment of
cZPR1 to restore the normal growth of yeast that express
the D5 mutant cZPR1, we studied the effect of cZPR1 mu-
tations on the subcellular localization of cZPR1 in S. cere-
visiae. The GFP-labeled NT and CT fragments of cZPR1
(NT—GFP and CT—GFP), like wild-type cZPR1-GFP, were
found to accumulate within the nucleus (Fig. 8 E). The dis-
tribution of the D5 mutant cZPR1-GFP (D5—GFP) was
similar to wild-type cZPR1—GFP (Fig. 8 E). Therefore, de-
letion of the D5 region did not affect the nuclear distribu-
tion of cZPR1 in growing cells. These data demonstrate
that cZPR1 can accumulate in the nucleus independently
of eEF-1a.
Table IV. Mutational Analysis of the Effect of ZPR1 on Yeast 
Viability and the Interaction of ZPR1 with eEF-1a
ZPR1 Complementation eEF-1a binding
Empty plasmid p413 ADH 2 2
WT 1 1
D1 1 1
D2 1 1
D3 1 2
D3 1 NT 1 1
D5 1 2
D5 1 NT 1 1
NT 2 1
CT 1 2
CT 1 NT 1 1
CT 1 NT (DD5) 1 2
MtZnF1 1 1
MtZnF2 2 1
Viability of haploid yeast (zpr1::LEU2) transformed with plasmid expression vectors
for wild-type and mutated ZPR1 proteins was scored as positive (1) or negative (2).
Binding of recombinant ZPR1 to eEF-1a was detected in vitro (1, 2).
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Figure 8. Mutational analysis of the effect of ZPR1 on the growth of the yeast S. cerevisiae. (A) The growth of haploid yeast strains
(zpr1::LEU2) complemented with plasmid expression vectors for wild-type (WT) and mutated (D1, D2, D3, D5, and NT) cZPR1 was
examined. Liquid cultures of the yeast (0.2 OD600) were serially diluted to 5-, 10-, 50-, 100- and 1,000-fold, spotted onto YEPD plates,
and then incubated at 308C. (B) The growth of haploid yeast strains (zpr1::LEU2) complemented with plasmid expression vectors for
wild-type (WT) and mutated (CT, NT, and NTDD5) cZPR1 was examined as described above. (C) Morphology of haploid yeast strains
(zpr1::LEU2) complemented with plasmid expression vectors for WT cZPR1 (strain LY1) and mutant D5 cZPR1 (strain LY6) was ex-
amined by microscopy using Nomarski optics. DNA was detected by DAPI staining and fluorescence microscopy. (D) FACS¤ analysis
of the haploid yeast strains LY1 and LY6 expressing wild-type and mutant (D5) cZPR1, respectively. (E) Mutational analysis of the
sub-cellular localization of cZPR1 in S. cerevisiae. The location of wild-type cZPR1 (cZPR1-GFP), D5 mutant cZPR1 (D5-GFP), the
NT fragment of cZPR1 (NT-GFP), and the CT fragment of cZPR1 (CT-GFP) was examined by fluorescence microscopy of yeast strains
MY28, LY11, LY12, and LY14, respectively (Table II). Bars: (C) 50 mm; (E) 10 mm.
 o
n
 July 8, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
 Published December 14, 1998
The Journal of Cell Biology, Volume 143, 1998 1482
Discussion
ZPR1 Is Conserved in Mammals and Yeast
ZPR1 is a zinc finger protein that was initially identified in
mammals (Galcheva-Gargova et al., 1996). This protein
contains two zinc fingers with the primary structure: Cys-
Xaa2-Cys-Xaa25-Cys-Xaa2-Cys. Atomic absorption spec-
troscopy confirmed the presence of two zinc atoms in each
ZPR1 molecule (Galcheva-Gargova et al., 1996). Here we
demonstrate that the ZPR1 protein is conserved in bud-
ding yeast (S. cerevisiae) and fission yeast (S. pombe). A
homologue of ZPR1 was also identified in the nematode
Caenorhabditis elegans by searching the GenBank data-
base (Wilson et al., 1994; GenBank/EMBL/DDBJ acces-
sion number AF022981) using the BLAST File Server
(National Center for Biotechnology Information, Be-
thesda, MD). The conserved structure of the ZPR1 pro-
teins from these diverse species indicates that the ZPR1
protein may have similar functions in higher and lower eu-
karyotes.
To examine the function of ZPR1 in eukaryotic cells, we
studied its role in the yeast S. cerevisiae. Gene disruption
experiments demonstrated that ZPR1 was essential for vi-
ability in S. cerevisiae. Deletion analysis and genetic com-
plementation assays demonstrated that the COOH-termi-
nal region of ZPR1 (including the second zinc finger) was
required for viability. In contrast, the NH2-terminal region
of ZPR1 (including the first zinc finger) was dispensable
for yeast viability.
The requirement for the COOH-terminal region of
cZPR1 for yeast viability may have evolutionary signifi-
cance. Prokaryotic homologues of ZPR1 have not been
described. However, prokaryotes may contain a homo-
logue of the COOH-terminal region of ZPR1. Conceptual
translation of the genomic sequences of several bacteria,
including Escherichia coli (Taura et al., 1992; GenBank/
EMBL/DDBJ accession number P25538), Synechococcus
sp. (Sugita et al., 1995; GenBank/EMBL/DDBJ accession
number P46227), Methanococcus jannaschii (Bult et al.,
1996; GenBank/EMBL/DDBJ accession number O57950),
Archaeoglobus fulgidus (Klenk et al., 1997; GenBank/
EMBL/DDBJ accession number AE00150), and Methano-
bacterium thermoautotrophicum (Smith et al., 1997; Gen-
Bank/EMBL/DDBJ accession number AE000936) indi-
cates the presence of a conserved hypothetical protein
with one zinc finger similar to the COOH-terminal region
of ZPR1. Whether these hypothetical prokaryotic zinc fin-
ger proteins share functions that are similar to the eukary-
otic ZPR1 proteins is presently unclear, but warrants fur-
ther study.
Nuclear Redistribution of ZPR1 in Proliferating Cells
The ZPR1 protein is located in the cytoplasm of quiescent
mammalian cells and redistributes to the nucleus after
treatment with mitogens (Galcheva-Gargova et al., 1996).
Immunofluorescence analysis demonstrated that the nu-
clear ZPR1 protein exhibited a punctate appearance. Dou-
ble-label immunofluorescence microscopy demonstrated
that nuclear ZPR1 colocalized with fibrillarin and RNA
polymerase I, but not with the splicing factor SC35 or p80
coilin (Galcheva-Gargova et al., 1998). The colocalization
with fibrillarin and RNA polymerase I suggests that ZPR1
accumulates within nucleoli.
Although ZPR1 is known to redistribute between the
cytoplasm and the nucleus in mammalian cells (Galcheva-
Gargova et al., 1996), it was unclear whether the subcellu-
lar localization of ZPR1 was regulated in yeast. Here we
demonstrate that ZPR1 redistributes between the cyto-
plasm and the nucleus in the yeast S. cerevisiae. In prolifer-
ating yeast, the ZPR1 protein was located preferentially in
the nucleus. In contrast, nutrient deprivation of yeast, like
serum starvation of mammalian cells, caused the redistri-
bution of ZPR1 from the nucleus to the cytoplasm. These
data indicate that ZPR1 responds to proliferative signals
in both mammals and yeast. Further studies are required
to determine the mechanism of nuclear exclusion and nu-
clear accumulation in response to altered proliferative
states.
Interaction of ZPR1 with eEF-1a in
Mitogen-treated Cells
The ZPR1 protein was found to bind eEF-1a. Coimmuno-
precipitation analysis demonstrated that ZPR1 did not
interact with eEF-1a in serum-starved mammalian cells.
In contrast, treatment with EGF or serum caused rapid in-
duction of ZPR1 complex formation with eEF-1a. Control
studies demonstrated that the formation of ZPR1/eEF-1a
complexes was selective because the treatment of cells
with phorbol ester did not cause coimmunoprecipitation
of eEF-1a and ZPR1. These data indicate that whereas
ZPR1 interacts with cell surface receptors in quiescent
cells (Galcheva-Gargova et al., 1996), ZPR1 binds to eEF-
1a after treatment of the cells with certain extracellular
stimuli.
eEF-1a is preferentially located in the cytoplasm of cells
(Edmonds et al., 1996; Minella et al., 1996). In contrast,
ZPR1 is located in the nucleus of mitogen-activated cells
(Galcheva-Gargova et al., 1996). The cytoplasmic location
of eEF-1a is incompatible with the evidence that nuclear
ZPR1 in mitogen-activated cells forms complexes with
eEF-1a. As eEF-1a is an abundant cellular protein, we
considered the possibility that the population of eEF-1a
molecules that form complexes with ZPR1 represents only
a fraction of the total eEF-1a present within the cell. To
test this hypothesis, we examined the nuclear accumula-
tion of eEF-1a in serum-starved and EGF-treated cells.
This analysis demonstrated that nuclear eEF-1a was not
detected in starved cells, but was detected in EGF-treated
cells. Interestingly, the nuclear eEF-1a exhibited a punc-
tate immunofluorescence appearance that was similar to
ZPR1. These data are consistent with the hypothesis that
mitogen-treatment of cells caused the formation of nu-
clear complexes of ZPR1 with eEF-1a. Further evidence
to support this interpretation was obtained from the ob-
servation that the treatment of cells with phorbol ester,
which does not cause the formation of ZPR1/eEF-1a
complexes, did not cause punctate nuclear localization of
eEF-1a.
The preferential location of eEF-1a in the cytoplasm is
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established (Edmonds et al., 1996; Minella et al., 1996) and
the presence of a nuclear subpopulation of eEF-1a has
been described (Collig et al., 1994; Janssen et al., 1994;
Barberse et al., 1995; Billaut-Mulot et al., 1996; Sanders et
al., 1996). These two populations of eEF-1a may play dif-
ferent physiological roles. The results of this study demon-
strate that nuclear eEF-1a includes complexes of eEF-1a
with ZPR1 in proliferating cells. Previous studies of eEF-
1a indicate that it can bind RNA (Blackwell and Brinton,
1997) and that it interacts with RNA polymerase poly-
merases (Blumenthal and Carmichael, 1979; Das et al.,
1998). One possible role of the nucleolar complex of eEF-
1a with ZPR1 is to functionally interact, directly or in-
directly, with RNA. The eEF-1a GTPase activity may
contribute to this putative regulatory function of the
ZPR1/eEF-1a complex.
Interaction of ZPR1 with eEF-1a Is Required for 
Normal Cellular Proliferation
Deletion analysis demonstrated that a short segment of
the NH2-terminal region of ZPR1 was required for the in-
teraction of ZPR1 with eEF-1a. Since the COOH-termi-
nal region of ZPR1 was sufficient for yeast viability, we
conclude that the interaction of ZPR1 with eEF-1a is not
required for viability. This conclusion was strongly sup-
ported by the observation that small in-frame deletions,
which disrupt binding to eEF-1a, did not affect the ability
of ZPR1 to confer viability. However, yeast strains ex-
pressing ZPR1 proteins that did not bind eEF-1a were
found to exhibit slow growth, aberrant morphology, and to
accumulate at the G2/M phase of the cell cycle. These data
indicate that the interaction of ZPR1 with eEF-1a may be
required for the normal proliferation of yeast. We tested
this hypothesis by performing an interallelic complemen-
tation assay using an NH2-terminal fragment of ZPR1
which binds to eEF-1a, but is insufficient for viability. This
fragment of ZPR1 complemented the defective growth of
yeast strains that express ZPR1 proteins that do not bind
eEF-1a. In contrast, deletion of sequences required for
eEF-1a binding to the NH2-terminal fragment of ZPR1
(NT DD5) blocked the interallelic complementation. These
data provide strong support for the hypothesis that the
binding of ZPR1 to eEF-1a is required for normal cellular
proliferation. Further studies are required to determine
whether the ZPR1/eEF-1a complex is required for prolif-
eration of mammalian cells. In addition, studies are re-
quired to establish the molecular mechanism of action of
the ZPR1/eEF-1a complex in vivo.
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